Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic and ophthalmic applications, announced that results from the clinical case series analyzing the UltraPulse® CO2 laser system will

This content is restricted to registered user. If you are an existing user, please log in. New users may register for free.

Existing Users Log In
   
New User Registration
 
 
 
 
 
 
Please indicate that you agree to the Terms of Service *
*Required field